MedPath

Mirapex

Mirapex (pramipexole dihydrochloride) 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, and 1.5 mg Tablets

Approved
Approval ID

b5504316-3907-444c-b604-ec9a18cdcd6d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 29, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

pramipexole dihydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-867
Application NumberNDA020667
Product Classification
M
Marketing Category
C73594
G
Generic Name
pramipexole dihydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 22, 2009
FDA Product Classification

INGREDIENTS (6)

pramipexole dihydrochlorideActive
Quantity: 0.500 mg in 1 1
Code: 3D867NP06J
Classification: ACTIB
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
povidoneInactive
Code: FZ989GH94E
Classification: IACT
starch, cornInactive
Code: O8232NY3SJ
Classification: IACT
colloidal silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mirapex - FDA Drug Approval Details